|
23 Oct 2020 |
Retrophin Announces Agreement to Acquire Orphan Technologies
|
|
19 Oct 2020 |
Genesis Therapeutics Enters AI-driven, Multi-Target Drug Discovery Partnership with Genentech
|
|
19 Oct 2020 |
Endo to Acquire BioSpecifics to Enhance Profitability of XIAFLEX® and Qwo™
|
|
17 Oct 2020 |
Denali Therapeutics to Highlight Progress Across Broad Biotherapeutics Portfolio for Neurodegeneration Enabled by Its Blood-Brain Barrier (BBB) TV Platform at Virtual R&D Day Today
|
|
16 Oct 2020 |
XL-protein and Antlia Bioscience Announce Collaboration to Develop Long-acting Peptide Therapy of Chronic Heart Failure using PASylation Technology
|
|
15 Oct 2020 |
Lilly Announces Agreement to Acquire Disarm Therapeutics
|
|
14 Oct 2020 |
Boehringer Ingelheim and Oxford BioTherapeutics Expand Collaboration to Discover Novel Selective Tumor Targets as First Bispecific Antibody Advanced into the Clinic
|
|
14 Oct 2020 |
Dyno Therapeutics Enters Collaboration and License Agreement with Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
|
|
14 Oct 2020 |
Secarna Pharmaceuticals and Denali Therapeutics Enter Into Research and Option Agreement to Develop Novel Antisense Therapies in the Field of Neurodegenerative Diseases
|
|
13 Oct 2020 |
Twist Bioscience and Neogene Announce Broad Strategic Partnership for Next Generation Personalized T Cell Therapies
|
|
12 Oct 2020 |
HitGen to Acquire Vernalis, a Leader in Structure-Based Drug Discovery
|
|
08 Oct 2020 |
The University of Tokyo and Eisai Announce Research Collaboration for the Development and Drug Discovery of Targeted Protein Degradation Technology
|
|
07 Oct 2020 |
Forbion Portfolio Company, Enterprise Therapeutics’ First-in-Class TMEM16A Potentiator Program for Treatment of Cystic Fibrosis and Other Respiratory Diseases Acquired by Roche
|
|
06 Oct 2020 |
Scribe Therapeutics to Collaborate With Biogen to Develop CRISPR-based Genetic Medicines for Neurological Diseases, Including Amyotrophic Lateral Sclerosis
|
|
06 Oct 2020 |
Chugai Enters into a License Agreement for Chugai’s Antibody Engineering Technologies with argenx
|
|
06 Oct 2020 |
BridgeBio Pharma and Eidos Therapeutics Announce Merger Agreement
|
|
06 Oct 2020 |
Mustang Bio Licenses LentiBOOST™ Technology from SIRION Biotech
|
|
06 Oct 2020 |
Nimble Announces Strategic Research Collaboration with Incyte to Discover Novel Peptide-Based Therapeutics
|
|
06 Oct 2020 |
Bristol Myers Squibb to Acquire MyoKardia for $13.1 Billion in Cash
|
|
02 Oct 2020 |
Covis Group Announces Agreement to Acquire AMAG Pharmaceuticals
|
|
30 Sep 2020 |
CStone, Pfizer Enter into Strategic Collaboration to Address Oncological Needs in China
|
|
21 Sep 2020 |
Bausch Health To Acquire Option To Purchase All Ophthalmology Assets Of Allegro Ophthalmics
|
|
21 Sep 2020 |
Scenic Biotech Enters Into Genetic Modifier Collaboration With Genentech
|
|
21 Sep 2020 |
Inflazome Announces Acquisition by Roche
|
|
18 Sep 2020 |
Elicio Therapeutics and Moffitt Collaborate to Study AMP-CD19 in Combination with CD19 CAR T Cells
|
